Merck MRK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. The Advantages of Owning Individual Stocks

      Headlines

      Sun, 3 May 2015

      fallen to 4% in recent years, I find the prospect of earning a 3% dividend on large, stable companies like Merck MRK "> MRK "> MRK "> MRK "> MRK "> MRK "> MRK "> MRK and General Electric GE "> GE "> GE "> GE "> GE "> GE "> GE

    2. Morningstar's Most Popular

      Headlines

      Fri, 1 May 2015

      General Electric Exxon Mobil Most Requested Stock Analyses Apple Chesapeake Energy Apollo Global Management Express Scripts Merck Most Requested Fund Quotes Fidelity Contrafund Vanguard Wellington Fidelity Select Biotechnology Portfolio Fidelity Magellan

    3. Friday Five: The Apple Surprise Worth Watching

      Video Reports

      Fri, 1 May 2015

      Lower-than-expected margins on the Apple Watch raise a yellow flag. Plus, Twitter earnings leak gets messy for shareholders, our read on the Fed's latest, and Merck shares look interesting.

    4. Gilead Sees Strong 1Q, Raises Guidance; High Cash Levels Mean Acquisitions Will Be Tough to Avoid

      Commentary

      Thu, 30 Apr 2015

      continued strong uptake of hepatitis C combo pill Harvoni. Despite the tough environment for Harvoni reimbursement and Merck 's potential launch later this year, we believe Gilead's portfolio and pipeline are diverse and innovative, and the

    5. RPT-Strong Merck cancer drug sales upstage rival Bristol-Myers

      Headlines

      Wed, 29 Apr 2015

      April 28 (Reuters) - Investors betting that Bristol-Myers Squibb will emerge as the leading player in a hot new class of cancer drugs hit the pause button on Tuesday as a rival therapy from Merck & Co showed much higher sales.

    6. This Pharma Firm Passes the Test

      Headlines

      Wed, 29 Apr 2015

      intellectual base buoy Merck 's MRK "> MRK "> MRK "> MRK ..... MRK "> MRK "> MRK "> MRK business and keep it well-shielded from the competition. Merck reported positive top-line ..... the market undervalues Merck 's pipeline, which not

    7. Strong Merck cancer drug sales upstage rival Bristol-Myers

      Headlines

      Tue, 28 Apr 2015

      April 28 (Reuters) - Investors betting that Bristol-Myers Squibb will emerge as the leading player in a hot new class of cancer drugs hit the pause button on Tuesday as a rival therapy from Merck & Co showed much higher sales.

    8. GLOBAL MARKETS-U.S. shares rebound; oil pares gains after Iran ship seizure

      Headlines

      Tue, 28 Apr 2015

      NEW YORK, April 28 (Reuters) - Two of three major U.S. stock indexes rose modestly on Tuesday as Merck posted strong earnings and IBM raised its dividend, while European stocks slid on weak corporate...

    9. Dow, S&P 500 end up with Merck , IBM; Nasdaq slips with Apple

      Headlines

      Tue, 28 Apr 2015

      (Reuters) - The Dow and S&P 500 ended a volatile session higher on Tuesday, helped by strong earnings from Merck and gains in IBM after it boosted its dividend, while the Nasdaq fell with Apple.

    10. GLOBAL MARKETS-U.S. shares edge higher; oil pares gains after Iran ship seizure

      Headlines

      Tue, 28 Apr 2015

      NEW YORK, April 28 (Reuters) - U.S. shares rebounded in afternoon trading on Tuesday, boosted by strong earnings from Merck and a dividend hike by IBM, while oil prices pared gains on expectations...

    « Prev12345Next »
    Content Partners